Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1988 |
Duvelisib
INK1197,IPI-145,度维利塞 |
PI3K | PI3K/Akt/mTOR signaling |
Duvelisib (INK1197) 是 p100δ的选择性抑制剂,能够作用于 p110δ (IC50:2.5 nM)、p110γ (IC50:27.4 nM)、p110β (IC50:85 nM) 和 p110α (IC50:1602 nM)。 | |||
T70802 |
Duvelisib hydrate
|
||
Duvelisib, also known as IPI-145 and INK-1197, is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. Upon administration, PI3K delta/gamma inhibitor IPI 145 prevents the activation of the PI3K delta/gamma-mediated signaling pathways which may lead to a reduction in cellular proliferation in PI3K delta/gamma-expressing tumor cells. Unlike oth... | |||
T11129 |
Duvelisib (R enantiomer)
Duvelisib R enantiomer,IPI-145 R enantiomer,INK1197 R enantiomer |
PI3K | PI3K/Akt/mTOR signaling |
Duvelisib R enantiomer (IPI-145 R enantiomer) 是一种 Duvelisib 的对映异构体,活性较低。 它是一种 PI3K 抑制剂。 | |||
T11129L |
Duvelisib (R enantiomer) hydrochloride
IPI-145 R enantiomer HCl,Duvelisib (R enantiomer) hydrochloride(1261590-48-0 Free base),INK1197 R enantiomer HCl |
PI3K | PI3K/Akt/mTOR signaling |
Duvelisib (R enantiomer) hydrochloride (INK1197 R enantiomer HCl) 是 PI3K 抑制剂。Duvelisib (R enantiomer) hydrochloride 是 Duvelisib 的活性较低的对映体。 |